Researchers tap registry to monitor drug safety
NCT ID NCT04682145
Summary
This study is collecting safety information from an existing European patient registry. It aims to monitor for any side effects in people with Hemophilia A who are being treated with the medication turoctocog alfa pegol. The study does not involve any new treatment or procedures for patients, as it only reviews data already reported to the registry.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novo Nordisk Investigational Site
Søborg, 2860, Denmark
Conditions
Explore the condition pages connected to this study.